Regulatory submission system integrating planning, authoring and publishing.
A connected regulatory submission system links three phases — project planning, document authoring, and the handoff to publishing — through one shared document core, so teams track deadlines, author from controlled content, and hand off submission-ready packages without re-keying data or losing version control.
Most regulatory teams don't lack tools. They have a project tracker for deadlines, a document repository for content, and a publishing vendor or internal team that turns everything into a submission-ready sequence. The problem is that these pieces rarely talk to each other, and every handoff between them is a place where a document goes stale, a task falls through, or a reviewer works from the wrong version.
- What does "integrated" actually mean for a submission system?
- Why do disconnected planning, authoring, and publishing break down?
- What core capabilities should a connected system provide?
- How does this hold up across multiple regions and products?
- What validation and compliance requirements apply?
- What should teams look for when evaluating a system?
- How do the common approaches compare?
- How does Kivo approach this?
- Frequently asked questions
What does "integrated" actually mean for a submission system?
An integrated regulatory submission system means planning, authoring, and the handoff to publishing all pull from the same underlying documents and metadata, so a change in one place is reflected everywhere else automatically.
That's a narrower claim than it sounds. It doesn't require one company's software to also perform eCTD publishing — plenty of well-run regulatory operations use a dedicated publishing partner or specialized tool for that last, highly technical step, and there are good reasons to keep that separate (more on this below). What it does require is that the project plan, the documents being authored, and the package that eventually goes to publishing are all versions of the same source of truth, not three disconnected systems that someone has to manually reconcile.
Why do disconnected planning, authoring, and publishing break down?
They break down because every handoff between separate systems is a manual step, and manual steps are where version control and deadlines fail.
A typical unintegrated setup looks like this: a project plan lives in a spreadsheet or a generic project tool, documents are authored and reviewed in a shared drive or a document management system that isn't connected to that plan, and the final submission-ready package is assembled by exporting, re-uploading, and re-organizing content into whatever the publishing tool or vendor requires. Each of those exports is a place where someone might grab an outdated draft, miss a just-approved revision, or lose track of which correspondence with a health authority affected which section.
The risk compounds with scale. A single product filing can involve hundreds of documents and dozens of contributors; a company running submissions across multiple regions or multiple products at once is coordinating that complexity many times over, often on overlapping timelines.
What core capabilities should a connected system provide?
A connected system needs three things working together: submission-level project tracking, document authoring tied to controlled content, and a structured, trackable handoff to publishing.
- Submission planning and tracking. Regulatory project plans — not generic task lists — with templatized content, owners, due dates, and dependencies that reflow automatically as a timeline shifts. Real-time reporting means a regulatory lead can see every open item across a submission, or across a whole portfolio of submissions, without chasing status updates.
- Authoring linked to a controlled document core. Documents used in a submission should be the same documents governed by the company's document control process — same version history, same approval workflow, same audit trail — rather than a copy that has to be kept in sync by hand. Native collaborative authoring (for example, real-time co-editing in Microsoft Word) reduces the friction that pushes teams back toward emailing drafts around.
- A structured handoff to publishing. Rather than a submission being "done" when a folder of files gets emailed to a publishing vendor, an integrated system produces a submission-ready package with automatic change tracking, so the publishing step starts from a known-current state and the regulatory team retains a linked, traceable copy after it's submitted.
How does this hold up across multiple regions and products?
It holds up by keeping one system of record regardless of how many submission sequences are running, so cross-regional dependencies and reused content stay visible instead of getting managed in parallel spreadsheets — the same portfolio-level visibility that matters for global submissions planning generally.
Global programs rarely move on a single track. A product might be under FDA review in the US while a related filing is in preparation for the EMA or another health authority, each with its own formatting expectations and timeline. A connected system gives regulatory leaders a portfolio-level view — every sequence, its status, and where content or deadlines depend on each other — instead of forcing someone to reconstruct that picture from separate trackers.
What validation and compliance requirements apply?
The system needs to demonstrate that its records are accurate, its audit trails are immutable, and its workflows behave as intended — the same bar regulators apply to any GxP computerized system.
For US submissions specifically, most drug applications — NDAs, ANDAs, BLAs, and commercial INDs, along with their amendments and supplements — must be submitted to FDA's Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) in the electronic Common Technical Document (eCTD) format; it's the FDA's standard for these submission types, not an optional convenience.[1] Underneath that formatting requirement sits the same 21 CFR Part 11 expectation that applies to any electronic record or signature involved in producing the submission: controlled access, a complete and uneditable audit trail, and validated software behind it. A system that can't produce that evidence on demand creates exposure well before a submission ever reaches a health authority.
What should teams look for when evaluating a system?
Look for genuine integration between planning, authoring, and the publishing handoff — not three modules from the same vendor that still require manual export and re-import between them.
Specific questions worth asking during evaluation:
- Do project plans, documents, and the submission package share the same underlying data, or does information have to be copied between them?
- Is validation evidence provided with every release, or does the customer's own QA team have to revalidate after each update?
- Can the system produce an audit-ready log of who changed what, and when, across the full submission lifecycle — not just within one module?
- Does the vendor lock content into a proprietary format, or can data be migrated out cleanly if the team ever needs to switch systems?
- How does the system handle the handoff to eCTD publishing — does it produce a clean, trackable package, or does content need to be reformatted by hand first?
Rather than inventing evaluation criteria from scratch, it's worth borrowing from an existing benchmark. Gens & Associates' ongoing "World Class RIM" research — an industry benchmark running since 2016, with its most recent edition drawing on insights from 59 organizations — assesses regulatory operations across process capabilities, organizational structure and competencies, data management and governance, and digital/technology capabilities.[3] Those four dimensions map fairly directly onto the integration question this article is about: a system scores well on "digital/technology capabilities" only if planning, authoring, and publishing genuinely share data rather than requiring manual reconciliation between modules.
It's also worth reading independent, unpaid user reviews rather than relying on vendor claims alone — G2's Regulatory Information Management (RIM) Systems category page aggregates verified user reviews across RIM vendors and is a reasonable starting point for that kind of independent perspective.
How do the common approaches compare?
The table below compares three general approaches life sciences teams take to regulatory submission planning, authoring, and publishing. This is not an independent ranking, and it doesn't assess implementation quality or fit for any particular organization — teams should validate any option against their own requirements.
| Approach | How it connects planning, authoring, and publishing | Where it tends to add manual work |
|---|---|---|
| Disconnected point tools | Separate project tracker, generic document storage, and a publishing vendor coordinated by email and manual export | Every handoff is manual; version control depends entirely on individual diligence |
| Enterprise suite with siloed modules | Regulatory, document management, and submission modules from one vendor, but built and validated separately | Data often still needs to be exported and re-imported between modules; implementation and validation are typically slower and costlier |
| Unified platform with a shared document core | Project plans, authored documents, and the publishing handoff package all reference the same underlying content and metadata | Publishing itself (the final eCTD build) is still typically handled by a dedicated publishing partner or tool, by design |
How does Kivo approach this?
Kivo is a unified compliance platform built around one shared, Part 11-compliant document core spanning Document Management, Regulatory Information Management (RIM), eTMF, and Quality Management — used today by 200+ sponsor, consultant, and CRO teams. Its regulatory submission software is where submission planning, authoring, and the publishing handoff come together.
Submission project plans in Kivo use templatized content and regulatory project structures, with due dates, owners, and dependencies that automatically reflow as a timeline shifts, plus real-time and scheduled reporting so a regulatory lead can see status across a whole portfolio of submissions. Documents used in those plans are authored directly against the same controlled DMS content everyone else in the organization works from — including native, real-time co-authoring in Microsoft Office — so there's no separate "submission copy" of a document to keep in sync.
Kivo deliberately does not perform eCTD publishing itself. Instead, it builds submission-ready packages, with automatic change tracking, for handoff to a customer's own internal team or external publishing partner — avoiding markup on a white-labeled third-party publishing tool and avoiding lock-in to one publishing vendor. Submitted eCTDs remain viewable inside Kivo afterward, linked back to their source documents, so the regulatory team retains one system of record rather than losing visibility the moment a submission goes out the door. Kivo also captures agency correspondence and commitments (emails, call logs, PDFs, scans) with automatic associations back to the relevant project and documents — a specific differentiator most legacy RIM tools handle as an afterthought, if at all.
Every release ships with validation evidence customers review and approve rather than re-performing themselves, cutting the time customers spend on software validation by 80–90%, and the platform is SOC 2 Type 2 and ISO 9001 certified. Kivo's own native, Part 11-compliant electronic signature is included with every subscription at no extra charge.
Frequently asked questions
What does a cloud-based regulatory submission system offer cross-functional teams?
A cloud-based system gives regulatory, clinical, and quality staff shared, real-time access to the same submission plans and documents from any browser, with no local IT infrastructure to maintain. That matters most when contributors span departments — a team working from one current version avoids the delays that come from emailing files or working from disconnected local copies.
What does an end-to-end system for pharma and biotech typically include?
End-to-end generally means submission project planning, document authoring against controlled content, and a structured handoff to eCTD publishing, all built on one document core — plus the audit trail, validation, and access controls needed to satisfy FDA, EMA, and other health authorities. Some platforms extend this further by connecting submissions to the same system used for clinical and quality documentation.
How does a submission system provide robust audit trails and tracking?
By automatically logging every action — document creation, edits, approvals, and status changes — with who made the change, when, and why, in a record that can't be edited or deleted after the fact. Combined with project-level tracking of deadlines and dependencies, this gives regulatory leaders both a real-time status view and an inspection-ready history for every submission.
Does Kivo's RIM module include eCTD publishing?
No. Kivo intentionally does not include eCTD publishing itself, to avoid marking up a white-labeled third-party tool or locking customers into one publishing vendor. It prepares submission-ready packages, with automatic change tracking, for handoff to a customer's chosen internal or external publishing partner, and keeps submitted eCTDs viewable and linked back to their source documents afterward.
How long does it take to implement a connected regulatory submission system?
Modern, pre-validated platforms are typically implemented in weeks rather than the six-plus months common with legacy enterprise systems, since validation evidence ships with every release instead of being built from scratch. Kivo's RIM implementation follows a five-step process — aligning on org structure, migrating documents and correspondence, loading validation evidence, a walkthrough, and training — before going live.
Sources
- U.S. Food and Drug Administration, "Electronic Common Technical Document (eCTD)" — eCTD as the mandatory format for NDA, ANDA, BLA, and commercial IND submissions to CDER/CBER.
- Grand View Research, "Regulatory Information Management System Market Report" — global RIM system market estimated at USD 1.78 billion in 2022, projected to reach USD 4.12 billion by 2030 (11.0% CAGR).
- Gens & Associates, "Regulatory Operational Excellence and World Class RIM" — ongoing industry benchmark since 2016; most recent edition based on insights from 59 organizations, assessing process capabilities, organizational structure/competencies, data governance, and digital/technology capabilities.
